You are here: Home / Areas of Care / Rebecca MacDonald Centre for Arthritis and Autoimmune Disease / Staff / Dr. Edward C. Keystone, M.D., FRCP(C)

Dr. Edward C. Keystone, M.D., FRCP(C)

  • Professor of Medicine, University of Toronto
  • Director, The Rebecca MacDonald Centre for Arthritis and Autoimmune Disease
  • Director, The Division of Advanced Therapeutics in Arthritis
  • Chairman, Canadian Rheumatology Research Consortium
  • Consultant, Rheumatology, Mount Sinai Hospital/University Health Network

Medical/Professional Training:
Dr. Keystone obtained his Doctorate of Medicine degree from the University of Toronto in 1969. After a further five years of training in Rheumatology, he received his specialty degrees (or fellowships) in both Rheumatology and Internal Medicine in 1974. He then carried out his research training at the Clinical Research Centre in Harrow, London, UK until 1976. He was on staff as a consultant rheumatologist at The Wellesley Central Hospital, Toronto, Canada from 1976 to 1998 before taking up his current position at Mount Sinai Hospital.

Professional and Academic Activities:
Dr. Keystone is a professor of Medicine at the University of Toronto. He is the Chairman of the Canadian Rheumatology Research consortium (CRRC), a not-for-profit corporation comprising academic and community rheumatologists devoted to enhancing the efficiency and quality of clinical trials in Canada. Dr. Keystone founded the Arthritis and Autoimmunity Research Centre, a multidisciplinary research centre devoted to epidemiological and translation research studies in autoimmune diseases at the University Health Network, from which he recently stepped down as its Co-director.

Dr. Keystone was recently appointed as Director of the Rebecca MacDonald Centre for Arthritis and Autoimmune Disease - a centre devoted to research into genomics, therapeutics, and outcomes in autoimmune inflammatory joint disease. He heads the Advanced Therapeutics Division which focuses on novel therapeutics in both rheumatoid arthritis and osteoarthritis. He is a consultant to the pharmaceutical and biotechnology industry and is a member of numerous biopharmaceutical advisory boards.

Dr. Keystone is also actively engaged in laboratory research studies of immune system abnormalities in Rheumatoid Arthritis and other autoimmune rheumatic diseases. He is the author of more than 170 peer-reviewed papers, reviews, and book chapters and has been the recipient of numerous teaching awards and honours, including the Senior Investigator Award of the Canadian Rheumatology Association.